|Articles|December 4, 2014
Biorasi Acquires European CRO, Advanced Biosciences Research
Biorasi LLC announced that it has completed the acquisition of Advanced Biosciences Research
Advertisement
Biorasi LLC, a global CRO, announced that it has completed the acquisition of Advanced Biosciences Research (ABR), a European CRO with operations in United Kingdom, Germany, Switzerland, and Sweden. ABR is a highly integrated group that has provided Phase II to IV clinical research project management, monitoring, and regulatory outsourcing for its sponsors in the region.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
5